HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+9.73%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$1.46B
AUM Growth
+$1.46B
(-4.8%)
Cap. Flow
-$147M
Cap. Flow
% of AUM
-10.05%
Top 10 Holdings %
Top 10 Hldgs %
55.54%
Holding
75
New
24
Increased
12
Reduced
12
Closed
20
Top Buys
| 1 |
Viatris
VTRS
|
$64.7M |
| 2 |
MDVN
MEDIVATION, INC.
MDVN
|
$64.4M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$63.4M |
| 4 |
Merck
MRK
|
$58.8M |
| 5 |
ENDP
Endo International plc
ENDP
|
$52.2M |
Top Sells
| 1 |
AGN
ALLERGAN INC
AGN
|
$96.4M |
| 2 |
ARTC
ARTHROCARE CORP
ARTC
|
$95.6M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$65.8M |
| 4 |
MJN
Mead Johnson Nutrition Company
MJN
|
$50.3M |
| 5 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$49.4M |
Sector Composition
| 1 | Healthcare | 74.33% |
| 2 | Financials | 5.64% |
| 3 | Technology | 1.7% |
| 4 | Consumer Staples | 0% |
| 5 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RGLS
26
DELISTED
Regulus Therapeutics
RGLS
| $14.2M | 0.85% |
13,125
-1,458
| -10% | -$1.58M |
|
27
Centene
CNC
$14.8B
| $14M | 0.84% |
+900,000
| New | +$14M |
|
|
AGN
28
DELISTED
Allergan plc
AGN
| $12.5M | 0.75% |
60,700
+33,800
| +126% | +$6.96M |
|
|
INFI
29
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $12.5M | 0.75% |
+1,050,000
| New | +$12.5M |
|
30
Pfizer
PFE
$141B
| $9.64M | 0.58% |
+316,200
| New | +$9.64M |
|
31
Dynavax Technologies
DVAX
$1.19B
| $8.67M | 0.52% |
479,498
-1,520,502
| -76% | -$27.5M |
|
32
Tenax Therapeutics
TENX
$27.5M
| $8.33M | 0.5% |
+47
| New | +$8.33M |
|
|
FPRX
33
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $8.2M | 0.49% |
416,944
-783,056
| -65% | -$15.4M |
|
34
Arrowhead Research
ARWR
$3.84B
| $7.39M | 0.44% |
+450,000
| New | +$7.39M |
|
|
VXRT
35
DELISTED
Vaxart
VXRT
| $7.03M | 0.42% |
+104,545
| New | +$7.03M |
|
|
ESRX
36
DELISTED
Express Scripts Holding Company
ESRX
| $6.91M | 0.42% |
+92,000
| New | +$6.91M |
|
37
Becton Dickinson
BDX
$54.3B
| $6.3M | 0.38% |
+55,145
| New | +$6.3M |
|
|
AGN
38
DELISTED
ALLERGAN INC
AGN
| $6.02M | 0.36% |
48,500
-776,500
| -94% | -$96.4M |
|
39
Novavax
NVAX
$1.2B
| $5.06M | 0.3% |
55,812
-174,188
| -76% | -$15.8M |
|
|
VIRX
40
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $4.56M | 0.27% |
+3,286
| New | +$4.56M |
|
41
Abbott
ABT
$230B
| $3.81M | 0.23% |
99,000
-18,300
| -16% | -$705K |
|
|
DSCI
42
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $3.8M | 0.23% |
+300,000
| New | +$3.8M |
|
|
CSII
43
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.64M | 0.16% |
83,000
+33,000
| +66% | +$1.05M |
|
|
ALXN
44
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $2.63M | 0.16% |
17,300
-432,700
| -96% | -$65.8M |
|
|
ELOS
45
DELISTED
Syneron Medical Ltd
ELOS
| $1.51M | 0.09% |
+121,500
| New | +$1.51M |
|
46
Rockwell Medical
RMTI
$59.6M
| $1.4M | 0.08% |
+10,027
| New | +$1.4M |
|
|
AEGR
47
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $1.15M | 0.07% |
24,800
-825,200
| -97% | -$38.1M |
|
48
Galmed Pharmaceuticals
GLMD
$7.07M
| $814K | 0.05% |
+394
| New | +$814K |
|
49
Alnylam Pharmaceuticals
ALNY
$58.6B
| – | – |
0
| – | – |
|
50
Biogen
BIIB
$20.8B
| – | – |
-27,800
| Closed | -$7.77M |
|